approved

Приложение 1 на ПЛС от 02.09.2020 г.

Unique identificator:  b5f8a4d3-3f63-4298-825c-f56a57f15c91

Description:

Приложение 1 на ПЛС от 02.09.2020 г.

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-09-04 10:16:20
  • Created by: georgi_sivchev
  • Updated at: 2020-09-04 10:16:20
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

C03CA01 Furosemide C03CA01 Furosemide
C03CA01 Furosemide FUROSER Solution for injection 10 mg/ml - 2 ml mg 10 Чайкафарма Висококачествените лекарства АД, България 40 mg - 17.7 3.54 17.7 50% 8.85 I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,N18.0,N18.8 НСР-5268/10.12.2014. 02.01.2015 08.09.2012 Заличен 572
C03CA01 Furosemide C03CA01 Furosemide
C03CA01 Furosemide Furantril Tablet 40 mg 12 Актавис EАД, България 40 mg - 1.73 0.0565 0.68 50% 0.34 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 НСР-6386/03.06.2015.; КП-76/05.10.2018 и НСР-16486/17.08.2018; НСР-20609/16.01.2020 02.02.2020 Активен 91
C03CA01 Furosemide Furantril Tablet 40 mg 12 Актавис EАД, България 40 mg - 1.44 0.04667 0.56 50% 0.28 I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,N18.0,N18.8 НСР-6385/03.06.2015 02.07.2015 Заличен 91
C03CA01 Furosemide Furosemide Sopharma Tablet 40 mg 20 Софарма АД, България 40 mg - 1.13 0.0565 1.13 50% 0.56 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 НСР-6575/29.06.2015. 02.07.2015 Активен 4027
C03CA01 Furosemide 100% C03CA01 Furosemide 100%
C03CA01 Furosemide Furantril Tablet 40 mg 12 Актавис EАД, България 40 mg 1.45 - 0.0475 0.57 100% 0.57 I10 HCP-8733/13.04.2016.; КП-76/05.10.2018 и НСР-16486/17.08.2018.; НСР-20609/16.01.2020 02.02.2020 Активен 91
C03CA01 Furosemide Furosemide Sopharma Tablet 40 mg 20 Софарма АД, България 40 mg 0.95 - 0.0475 0.95 100% 0.95 I10 HCP-8734/13.04.2016. 02.08.2019 Активен 4027
C03CA04 Torasemide C03CA04 Torasemide
C03CA04 Torasemide TORAZIDEX Tablet 5 mg 30 Sandoz d.d., Словения 15 mg - 6.73 0.505 5.05 50% 2.53 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 № 162/ 20.04.2011; НСР-817/07.08.2013; НСР-3283/24.04.2014; НСР-8366/26.02.2016; НСР-13345/28.07.2017; НСР-15798/08.06.2018 02.07.2018 08.09.2012 Активен 2728
C03CA04 Torasemide TORAZIDEX Tablet 10 mg 30 Sandoz d.d., Словения 15 mg - 11.63 0.505 10.1 50% 5.05 I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 № 162/ 20.04.2011; НСР-15798/08.06.2018 02.07.2018 08.09.2012 Активен 997
C03CA04 Torasemide Torsit SR Prolonged release tablet 10 mg 30 Ferrer International S.A.,, Испания 15 mg - 10.1 0.505 10.1 50% 5.05 I11.0,I12.0,I13.0,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 КЦРР-1662/20.11.2012 г. НСР-899/09.08.2013; НСР-2964/07.03.2014; НСР-19358/26.07.2019 02.09.2019 Активен 2096
C03CA04 Torasemide Torsit SR Prolonged release tablet 5 mg 30 Ferrer International S.A.,, Испания 15 mg - 5.05 0.505 5.05 50% 2.53 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 КЦРР-1662/20.11.2012 г.; НСР-898/09.08.2013; НСР-2964/07.03.2014; НСР-4930/22.10.2014; HCP-10138/31.08.2016; НСР-19357/26.07.2019 02.09.2019 Активен 3317
C03CA04 Torasemide TRIFAS Tablet 10 mg 30 Menarini International Operations Luxembourg S.A., Люксембург 15 mg - 13.09 0.505 10.1 50% 5.05 I50.0,I50.1 № 66/ 08.04.2010; № 77/ 22.04.2010; № 85/17.06.2010 02.10.2013 08.09.2012 Активен 537
C03CA04 Torasemide TRIFAS COR Tablet 5 mg 30 Menarini International Operations Luxembourg S.A., Люксембург 15 mg - 8.74 0.505 5.05 50% 2.53 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 № 66/ 08.04.2010; № 77/ 22.04.2010; № 85/17.06.2010; НСР-19789/10.09.2019 02.10.2019 08.09.2012 Активен 536
C03CA04 Torasemide 100% C03CA04 Torasemide 100%
C03CA04 Torasemide TORAZIDEX Tablet 5 mg 30 Sandoz d.d., Словения 15 mg 5.68 - 0.426 4.26 100% 4.26 I10 HCP-8735/13.04.2016; НСР-13345/28.07.2017 02.08.2019 08.09.2012 Активен 2728
C03CA04 Torasemide Torsit SR Prolonged release tablet 5 mg 30 Ferrer International S.A.,, Испания 15 mg 4.26 - 0.426 4.26 100% 4.26 I10 HCP-10138/31.08.2016; НСР-19357/26.07.2019 02.09.2019 Активен 3317
C03CA04 Torasemide TRIFAS COR Tablet 5 mg 30 Menarini International Operations Luxembourg S.A., Люксембург 15 mg 7.36 - 0.426 4.26 100% 4.26 I10 НСР-19789/10.09.2019 02.10.2019 08.09.2012 Активен 536
C03DA01 Spironolactone C03DA01 Spironolactone
C03DA01 Spironolactone SPIRONOLACTON ACTAVIS Coated tablet 25 mg 30 Актавис EАД, България 75 mg - 5.08 0.35975 3.6 25% 0.9 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 02.11.2019 08.09.2012 Активен 235
C03DA01 Spironolactone Spironolactone Accord Film coated tablet 25 mg 30 Accord Healthcare Polska Sp. z.o.o., Полша 75 mg - 5.34 0.35975 3.6 25% 0.9 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 НСР-16552/24.08.2018; НСР-20110/08.11.2019 02.12.2019 Активен 16236
C03DA01 Spironolactone Spironolactone Accord Film coated tablet 50 mg 30 Accord Healthcare Limited, Обединено Кралство 75 mg - 12.01 0.35975 7.2 25% 1.8 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 НСР-16552/24.08.2018 02.11.2019 Активен 16237
C03DA01 Spironolactone SPIRONOLACTON-TCHAIKAPHARMA Film coated tablet 50 mg 30 Чайкафарма Висококачествените лекарства АД, България 75 mg - 9.82 0.35975 7.2 25% 1.8 I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 НСР-5070/21.11.2014; НСР-18142/07.03.2019; НСР-21674/11.06.2020 02.07.2020 08.09.2012 Активен 3369
Showing 876 to 901 of 4514 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте